. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Transplantation. 2021 Jun 1;105(6):1297–1302. doi: 10.1097/TP.0000000000003361

Table 1:

Basic demographic data comparing patients who underwent re-LT versus those who had a single transplant (LDLT only).

Variable	Re-LT (n=110)	LDLT only (n=955)	P-value
Male, N (%)	72 (65.5%)	548 (57.4%)	0.13
Caucasian	104 (94.5%)	849 (89.8%)	1.00
Age at LDLT, median (IQR)	49 (41–57)	53 (46–59)	<0.001
BMI, median (IQR)	25 (23–28)	26 (23–30)	0.11
MELD, median (IQR)	16 (12–20)	15 (11–19)	0.11
ALD, N (%)	17 (15.5%)	151 (15.8%)	1.00
HCV, N (%)	50 (45.5%)	353 (37.0%)	0.10
NASH or cryptogenic cirrhosis, N (%)	10 (9.1%)	96 (10.0%)	0.75
Cholestatic disease, N (%)^*	23 (20.9%)	219 (22.9%)	0.63
HCC, N (%)	12 (10.9%)	157 (16.4%)	0.17
Left lobe, N (%)	68 (7.1%)	7 (6.4%)	1.00
Related donor, N (%)	65 (59.1%)	633 (66.4%)	0.14

Cholestatic disease included primary biliary cholangitis and primary sclerosing cholangitis.